ReShape Lifesciences (Formally known as EnteroMedics)

280 articles about ReShape Lifesciences (Formally known as EnteroMedics)

• EnteroMedics Reports Fourth Quarter 2011 Financial Results

  1/26/2012

• EnteroMedics Announces Completion of Patient Enrollment and Device Implantation in the ReCharge Pivotal Trial for Obesity

  12/28/2011

• EnteroMedics Receives First Approval for the Active Implantable Medical Device Components of the Maestro System From Australian Therapeutic Goods Administration (TGA)

  12/13/2011

• EnteroMedics to Present at the Canaccord Adams Genuity Sixth Annual Cardiovascular, Aesthetics and Metabolic Disorders Conference

  11/29/2011

• EnteroMedics to Present at the 23rd Annual Piper Jaffray Healthcare Conference

  11/22/2011

• EnteroMedics to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

  11/7/2011

• EnteroMedics Reports Third Quarter 2011 Financial Results

  10/21/2011

• EnteroMedics Announces Updated Data From VBLOC DM2 ENABLE Study and Caloric Intake Study Results to be Presented at the 29th Annual Obesity Society Meeting

  10/3/2011

• EnteroMedics to Present at the Craig-Hallum 2nd Annual Alpha Select Conference

  9/30/2011

• EnteroMedics Announces Pricing of $14.5 Million Public Offering of Common Stock and Warrants

  9/23/2011

• EnteroMedics Announces Presentation of Maestro(R) RC System Clinical Data at the XVI World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders

  9/2/2011

• EnteroMedics to Present at the Canaccord Adams Genuity Annual Growth Conference

  8/2/2011

• EnteroMedics Reports Second Quarter 2011 Financial Results

  7/21/2011

• EnteroMedics Announces Maestro(R) RC System Updated Weight Loss Data to Be Presented at the American Society for Metabolic & Bariatric Surgery Annual Meeting

  6/14/2011

• EnteroMedics Announces First Implant in ReCharge Pivotal Trial for Obesity

  5/19/2011

• EnteroMedics Reports First Quarter 2011 Financial Results

  4/25/2011

• EnteroMedics Receives CE Mark Certification for the Maestro RC System, Allowing Australian Regulatory Application to Move Forward

  3/29/2011

• EnteroMedics Receives CE Mark Certification for the Maestro RC System

  3/28/2011

• EnteroMedics to Participate in 3rd Annual Lazard Capital Markets Medical Technology Conference

  2/14/2011

• EnteroMedics Reports Fourth Quarter and Full Year 2010 Financial Results

  1/28/2011